• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18464 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of a model for predicting emergency hospital admission and readmission in Catalonia]
2014     National Evidence-based Healthcare Collaborating Agency (NECA) [Development of a preference-based instrument: Asian Comparative Study]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of a shared knowledge system for network assessment of technological innovation in medicine]
2014     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Development of appropriateness criteria for transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis]
2014     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Development of composite indicators to measure the quality of prevention and chronic management activities for gynecological cancer screening in primary care]
2009     Andalusian Health Technology Assessment Area (AETSA) [Development of criteria, complexity indicators and management strategies on frailty]
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Development of decision-aid: HPV-patient information]
2009     National Evidence-based Healthcare Collaborating Agency (NECA) [Development of empirical treatment guidelines in febrile neutropenic patients on the basis of the Korean data]
2016     National Evidence-based Healthcare Collaborating Agency (NECA) [Development of evidence-based clinical imaging guidelines : to supply the evidence for appropriateness of diagnostic imaging studies and radiation exposure levels of patients]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of indicators to assess prevention programs for colorectal cancer in high risk populations]
2013     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Development of quality indicators for laser treatment for benign prostatic hyperplasia. Expert consensus]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of scientific concepts for the generation of routine practice data and their analysis for the benefit assessment of drugs according to §35a Social Code Book V – rapid report]
2011     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Diabetic foot ulcers - a health technology assessment]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Diagnosis and consumption of drugs for Alzheimer's disease in the Basque country]
2013     The Swedish Council on Health Technology Assessment (SBU) [Diagnosis and treatment of ADHD and ASDs (autism spectrum disorders)]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Diagnosis and treatment of chronic cerebrospinal venous insufficiency (CCSVI) for people with multiple sclerosis]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Diagnosis and treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in people with Multiple Sclerosis (MS)]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Diagnosis and treatment of obstructive sleep apnoea - a health technology assessment]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Diagnosis of gestational diabetes mellitus: evaluation of the new IADPSG criteria]
2004     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Diagnostic accuracy and clinical usefulness of Positron Emission Tomography (PET) in breast and ovarian cancer recurrence]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Diagnostic accuracy of anti-CCP antibody test in rheumatoid arthritis: systematic review]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Diagnostic and therapeutic approach to non complex duodenal ulcer]
2009     The Regional Health Technology Assessment Centre (HTA-centrum) [Diagnostic colon evaluation in patients with suspected colorectal neoplasia or at high risk of colorectal neoplasia - a comparison of double contrast barium enema (DCBE), CT colonography and colonoscopy]
2005     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Diagnostic effectiveness, security and clinical usefulness of capsule endoscopy in the diagnosis of small bowel disorders]
2008     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Diagnostic evaluation and treatment of dementia – a health technology assessment]
2014     The Swedish Council on Health Technology Assessment (SBU) [Diagnostic imaging in suspected prostate cancer]
2014     The Swedish Council on Health Technology Assessment (SBU) [Diagnostic imaging in the staging of prostate cancer]
2008     Andalusian Health Technology Assessment Area (AETSA) [Diagnostic performance of clinical prediction models for pulmonary embolism]
2009     Andalusian Health Technology Assessment Area (AETSA) [Diagnostic performance of digital mammography in breast cancer screening]
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Diagnostic performance of techniques used for HER-2 testing in breast cancer]
2002     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Diagnostic radiology using transportable equipment]
2019     National Committee for Technology Incorporation (CONITEC) [Diagnostic tests for thrombophilia in pregnancy]
2014     National Evidence-based Healthcare Collaborating Agency (NECA) [Diagnostic usefulness of brain FDG-PET for Alzheimer's dementia]
2016     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Diagnostics and treatment for endometriosis – a systematic review]
2016     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Diagnostics and treatment for epilepsy – a systematic review]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Dialysis in chronic renal failure - a health technology assessment]
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Dietary guidance in the primary health care sector (co-funded by DIHTA)]
2010     The Swedish Council on Health Technology Assessment (SBU) [Dietary treatment of diabetes]
2013     The Swedish Council on Health Technology Assessment (SBU) [Dietary treatment of obesity]
2009     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Different antihypertensive drugs as first-line therapy in patients with essential hypertension]
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Differential diagnostic of the burnout syndrome]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Digital Breast Tomosynthesis]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Digital dermatoscopy for dysplastic nevi]
2012     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Digital hearing aid in comparison with analog hearing aid for presbycusis: evaluation of the clinical effectiveness and the cost-effectiveness]
2011     Basque Office for Health Technology Assessment (OSTEBA) [Digital mammograms in breast cancer screening. Assessment of their efficiency and inclusion in the Early Breast Cancer Detection Programme of the Basque Country]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Digital tomosynthesis for breast cancer]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Digital tomosynthesis for the diagnosis of breast cancer]
2018     Andalusian Health Technology Assessment Area (AETSA) [Digital tomosynthesis in breast cancer: meta-analysis]
2012     Andalusian Health Technology Assessment Area (AETSA) [Digital tomosynthesis of the breast]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dimethyl fumarate (psoriasis) - benefit assessment according to §35a Social Code Book V]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dimethyl fumarate in multiple sclerosis: Comparison among different commercially available trademarks in Argentina]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dimethyl fumarate in multiple sclerosis: Comparison among different commercially available trademarks in Argentina]
2014     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dimethyl fumarate: benefit assessment according to section 35a Social Code Book V (dossier assessment)]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dinutuximab for patients with high-risk neuroblastoma]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Diode laser vaporization in benign prostatic hyperplasia]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Dipeptidyl peptidase-4 (dpp4) inhibitors in diabetes mellitus]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dipeptidyl peptidase-4 inhibitors as treatment for diabetes mellitus]
2011     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dipyridamole and aspirin for secondary prevention after stroke or TIA]
2021     Institute for Clinical Effectiveness and Health Policy (IECS) [Direct-acting oral anticoagulants for postoperative thrombosis prophylaxis]
2013     Norwegian Knowledge Centre for the Health Services (NOKC) [Discharging patients with chronic disease: effect of various forms of cooperation between hospital and the community health service]
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) [Disinfection chambers/tunnels in the context of COVID-19 pandemic]
2011     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Dissemination of HTA products. New lines of action]
2002     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [DMARD therapy of rheumatoid arthritis, systematic review of the clinical and economic literature]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dolutegravir (HIV infection) - addendum to commission A17-11]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dolutegravir (HIV infection) - benefit assessment according to §35a Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Dolutegravir for the treatment of pregnant women living with HIV]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dolutegravir, Abacavir and Lamivudine (Triumeq®) in HIV infection]
2014     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dolutegravir: benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dolutegravir/abacavir/lamivudine - benefit assessment according to section 35a Social Code Book V (dossier assessment)]
1999     Basque Office for Health Technology Assessment (OSTEBA) [Domiciliary oxygen therapy]
2009     The Swedish Council on Health Technology Assessment (SBU) [Dopaminergic agents in treating restless legs syndrome]
2011     Haute Autorite de sante (HAS) [Dressings: indications and recommended uses]
2005     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Drotrecogin alfa in the treatment of severe sepsis]
2014     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Drug combination of emtricitabine, rilpivirine and tenofovir disoproxil (new therapeutic indication): benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Drug treatment of ADHD (Attention Deficit/Hyperactivity Disorder) in adults in Germany]
2016     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Drug treatment of children with respiratory tract infections]
2010     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Drug treatment of hypertension - update search (rapid report)]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Drug-eluting balloon for the treatment of coronary stenosis]
2014     The Swedish Council on Health Technology Assessment (SBU) [Drug-eluting stents in coronary arteries]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Drug-eluting stents in coronary heart disease]
2009     National Evidence-based Healthcare Collaborating Agency (NECA) [Drug-eluting stents versus bare-metal stents in acute myocardial infarction]
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease]
2005     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Drug-eluting stents with rapamycin or paclitaxel versus conventional stents]
2010     Norwegian Knowledge Centre for the Health Services (NOKC) [Drugs for smoking cessation]
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Drugs in oncology: an overview of benefit and refund practices in Europe]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dual target deep brain stimulation in refractory dystonia]
2015     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dulaglutide (addendum to Commission A15-07)]
2015     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dulaglutide: benefit assessment according to §35a Social Code Book V (dossier assessment)]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Duodeno-jejunal bypass liner (DJBL) for patients with obesity, with/without type 2 diabetes mellitus]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Dupilumab in atopic dermatitis not adequately controlled with atopical therapy]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic fixation for spine degenerative diseases]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic magnetic resonance imaging for focal liver lesion assessment]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic magnetic resonance imaging for focal liver lesion assessment]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic magnetic resonance imaging in pelvic floor dysfunction]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic stabilization with interspinous devices for spinal conditions]
2014     The Swedish Council on Health Technology Assessment (SBU) [Dyslexia in children and adolescents – tests and interventions]
2015     Basque Office for Health Technology Assessment (OSTEBA) [E-health systems to support cancer patients: proposal for the design of future assessment studies]
2010     The Swedish Council on Health Technology Assessment (SBU) [Early and focused ultrasonography in physical trauma]
1994     Basque Office for Health Technology Assessment (OSTEBA) [Early detection of breast cancer in the Basque Country]